Mankind Pharma Launches Empagliflozin Generic, Sees Stock Rebound Amid Market Expansion
Mankind Pharma’s recent launch of a generic diabetes medication and strong market performance suggest a promising future, but investors must weigh potential growth against a high price-to-earnings ratio and market volatility.
2 minutes to read